• nPhase Mixes Data, Evidence in One Platform, N-Power Medicine, VieCure Enter Partnership, More

    Clinical Research News | nPhase launches the first industry platform to harmonize real-world evidence and clinical trial data in one system; N-Power Medicine and VieCure have entered a strategic partnership; and more.

    Sep 25, 2025

  • Follow the Money: Adjustment Disorder Clinical Trial, Solving Trial Recruitment Failure, More

    Clinical Research News | Reunion Neuroscience will continue with its ongoing REKINDLE Phase 2 clinical trial in Adjustment Disorder (AjD) in cancer; Trially has launched Margo, an agentic AI solution that multiplies trial enrollment by converting patient matches into participants; and more.

    Sep 24, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Building Momentum: Strengthening Patient Retention in Clinical Trials

    Clinical Research News | In clinical research, keeping patients engaged throughout the course of a trial is not only a logistical goal but a scientific necessity. Retention ensures that datasets remain complete, representative, and reliable. High dropout rates, by contrast, mean gaps in data, higher costs to backfill participants, and extended timelines that frustrate everyone involved.

    Sep 19, 2025

  • Psilocybin Shows Potential as Candidate for Delayed Aging

    Clinical Research News | Psilocybin—the psychoactive compound found in “magic mushrooms”—has often been viewed in a negative light due to the reputation of psychedelics, even among experts. But new research suggests that the compound could have a role in slowing the aging process.

    Sep 16, 2025